Anti-thymocyte globulin (rabbit) Interactions
There are 150 drugs known to interact with anti-thymocyte globulin (rabbit), along with 2 disease interactions. Of the total drug interactions, 46 are major, 97 are moderate, and 7 are minor.
- View all 150 medications that may interact with anti-thymocyte globulin (rabbit)
- View anti-thymocyte globulin (rabbit) disease interactions (2)
Most frequently checked interactions
View interaction reports for anti-thymocyte globulin (rabbit) and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- AndroGel (testosterone)
- Centrum (multivitamin with minerals)
- Cipro (ciprofloxacin)
- Clomid (clomiphene)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Cotrim (sulfamethoxazole / trimethoprim)
- Cotrim DS (sulfamethoxazole / trimethoprim)
- Dextrose 5% in Lactated Ringer's Injection (lvp solution)
- Effexor XR (venlafaxine)
- Folinic-Plus (multivitamin)
- Gamunex-C (immune globulin intravenous and subcutaneous)
- Indium In-111 DTPA (indium pentetate in-111)
- Malarone (atovaquone / proguanil)
- Neurontin (gabapentin)
- Nicotinamide ZCF (multivitamin with minerals)
- Norgesic (aspirin / caffeine / orphenadrine)
- Paracetamol (acetaminophen)
- Penicillin VK (penicillin v potassium)
Anti-thymocyte globulin (rabbit) disease interactions
There are 2 disease interactions with anti-thymocyte globulin (rabbit) which include:
More about anti-thymocyte globulin (rabbit)
- anti-thymocyte globulin (rabbit) consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.